您好,欢迎来到易推广 请登录 免费注册

上海陶术生物科技有限公司 主营产品:生物试剂,实验服务等

当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示

企业档案

会员类型:会员

已获得易推广信誉   等级评定
139成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

易推广会员:5

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

企业类型:生产商 【已认证】

注册资金:人民币万 【已认证】

产品数:86101

参观次数:3777892

手机网站:http://m.yituig.com/c135739/

旗舰版地址:http://tsbiochem.app17.com

自主品牌

已选条件

  • T4687Ro5-3335CBFβ-Runx1 inhibitor II;Ro 5-3335

    Ro 5-3335 is core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM). It represses RUNX1/CBFβ-dependent transactivation in reporter assays and inhibits transcriptional regulation by RUNX

    价 格:¥电议型 号:T4687产 地:中国大陆

  • T4687Ro 5-3335Ro 5-3335,CBFβ-Runx1 inhibitor II,

    Ro 5-3335 is core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM). It represses RUNX1/CBFβ-dependent transactivation in reporter assays and inhibits transcriptional regulation by RUNX

    价 格:¥电议型 号:T4687产 地:美洲

  • T4687Ro5-3335;化合物Ro 5-3335CBFβ-Runx1 inhibitor II|||Ro 5-3335;CBFβ-Runx1 inhibitor II|||Ro 5-3335

    Ro5-3335 (CBFβ-Runx1 inhibitor II) is core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM). Ro5-3335 represses RUNX1/CBFβ-dependent transactivation in reporter assays and inhibits transcriptional regulation by RUNX1 and CBFβ. Ro5-3335 also reduces the leukemia burden in a mouse model. Attenuates RUNX1-dependent hematopoiesis in zebrafish embryos. It also is a Tat antagonist and inhibits HIV-1 replication in vitro.

    价 格:¥电议型 号:T4687产 地:中国大陆

1共1页

快速导航

在线咨询

提交